3
by Lachance, Chantelle, Frey, Nina
Published 2020
Canadian Agency for Drugs and Technologies in Health
... cessation among youth, specific evidence is required. As such, this report aims to review the clinical...

4
by Lachance, Chantelle, Frey, Nina
Published 2020
Canadian Agency for Drugs and Technologies in Health
... cessation among youth, specific evidence is required. As such, this report aims to review the clinical...

5 ... the clinical and cost-effectiveness, as well as guidelines for the use of DBS in the treatment of PD...

6 ... the clinical and cost-effectiveness, as well as guidelines for the use of DBS in the treatment of PD...

7
by Lachance, Chantelle, Wright, Mary-Doug
Published 2019
Canadian Agency for Drugs and Technologies in Health
.... This report aims to summarize the evidence regarding the clinical effectiveness and evidence-based guidelines...

8
by Lachance, Chantelle, Wright, Mary-Doug
Published 2019
Canadian Agency for Drugs and Technologies in Health
.... This report aims to summarize the evidence regarding the clinical effectiveness and evidence-based guidelines...

9
by Lachance, Chantelle, Walter, Melissa
Published 2020
Canadian Agency for Drugs and Technologies in Health
... or suspected malignancies for lung cancer. No evidence regarding the cost-effectiveness, clinical utility...

10
by Lachance, Chantelle, Walter, Melissa
Published 2020
Canadian Agency for Drugs and Technologies in Health
... or suspected malignancies for lung cancer. No evidence regarding the cost-effectiveness, clinical utility...

11
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
...The aim of this report is to summarize the evidence regarding both the clinical...

12
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
...The aim of this report is to summarize the evidence regarding both the clinical effectiveness...

13
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
...The aim of this report is to summarize the evidence regarding both the clinical effectiveness...

14
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
...The aim of this report is to summarize the evidence regarding both the clinical...

15
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
CADTH
...The aim of this report is to summarize the evidence regarding the clinical and cost effectiveness...

16
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
CADTH
...The aim of this report is to summarize the evidence regarding the clinical and cost effectiveness...

17
by Lachance, Chantelle, Argáez, Charlene
Published 2019
Canadian Agency for Drugs and Technologies in Health
.... Despite being used in the health care setting, it is unclear if these cleansers are more clinically...

18
by Lachance, Chantelle, Argáez, Charlene
Published 2019
Canadian Agency for Drugs and Technologies in Health
.... Despite being used in the health care setting, it is unclear if these cleansers are more clinically...

19
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
CADTH
... aims to summarize evidence regarding the clinical and costeffectiveness, as well as guidelines...

20
by Lachance, Chantelle, McCormack, Suzanne
Published 2019
CADTH
... aims to summarize evidence regarding the clinical and costeffectiveness, as well as guidelines...